Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease—indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey-Reference-Cited by-同舟云学术

Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease—indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey

Published:2017-04 Issue:4 Volume:19 Page:660-664
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Haugaa Kristina H.,Tilz Roland,Boveda Serge,Dobreanu Dan,Sciaraffia Elena,Mansourati Jacques,Papiashvili Giorgi,Dagres Nikolaos

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/19/4/660/13692215/eux089.pdf

Reference13 articles.

1. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death;Europace,2015

2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;Eur Heart J,2016

3. Screening and risk evaluation for sudden cardiac death in ischaemic and non-ischaemic cardiomyopathy: results of the European Heart Rhythm Association survey;Europace,2013

4. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy;N Engl J Med,2004

5. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT);Circulation,2002

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy;Heart Failure Clinics;2024-10

2. Left Atrium Reverse Remodeling in Fusion CRT Pacing: Implications in Cardiac Resynchronization Response and Atrial Fibrillation Incidence;Journal of Clinical Medicine;2024-08-15

3. Clinical characteristics, treatment, trajectories and outcome of patients with dilated cardiomyopathy in a national heart failure registry;International Journal of Cardiology;2024-07

4. Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias;Scientific Reports;2024-06-27

5. Which patients with non‐ischaemic cardiomyopathy should receive a defibrillator?;European Journal of Heart Failure;2024-05-15